Litigation
May 3, 2013
$6.5 million Actos verdict overturned, expert testimony inadmissable
Asia's biggest drugmaker won an unexpected victory Tuesday when a judge overturned last week's ruling that its blockbuster diabetes drug caused a plaintiff's cancer. The ruling throws into question the outcome of 3,000 pending cases.
Daily Journal Staff Writer
LOS ANGELES - Takeda Pharmaceuticals America Inc., the maker of the diabetes medication Actos, does not have to pay the $6.5 million that a jury last week awarded to a cancer patient who sued the company over the drug, a state court ruled Tuesday.
Los Angeles County Superior Court Judge Kenneth R. Freeman effectively nullified the verdict after determining that the expert testimony of a key witne...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In